Key result
TMAO drives cardiac aging and diastolic dysfunction in mice via NLRP3-mediated pyroptosis.
Why the study?
Does trimethylamine N-oxide (TMAO) promote cardiac aging through NLRP3-mediated pyroptosis in mice?
Does trimethylamine N-oxide (TMAO) promote cardiac aging through NLRP3-mediated pyroptosis in mice?
TMAO contributes to cardiac aging and diastolic dysfunction via NLRP3-mediated pyroptosis driven by oxidative stress, suggesting that inhibiting TMAO generation may be a potential therapeutic strategy.
Answers are grounded in this paper and cite their sources.
TMAO may promote diastolic dysfunction via pyroptosis in mice; leaves open whether targeting TMAO or GSDMD benefits human HFpEF.
AIMS The present study was aimed to investigate whether trimethylamine N-oxide (TMAO) contributed to cardiac aging and to explore the underlying mechanism. MATERIALS AND METHODS Male C57BL/6 J mice were randomly divided into four age groups (3, 12, 18, and 24 months) to assess the cardiac function. Markers of senescence, oxidative stress, and the protein expression of pyroptosis were also measured. To test the hypothesis that TMAO promoted cardiac aging, 8-week-old mice were intraperitoneally injected with TMAO for 1-3 months and 3,3-dimethyl-1-butanol was administered in drinking water starting from 15 months of age for three months to inhibit TMAO production. Gasdermin D (GSDMD) knockout mice were also used. KEY FINDINGS Plasma TMAO levels increased with age and correlated with upregulation of cardiac senescence markers, diastolic dysfunction, cardiac fibrosis, and elevated plasma brain natriuretic peptide levels. Starting from 2 months of TMAO treatment, impairment of cardiac diastolic function and progression of cardiac fibrosis were observed alongside the upregulation of senescence marker proteins expression. Mechanistically, TMAO promoted cardiac oxidative stress and activated the NLRP3-mediated pyroptosis pathway. Genetic ablation of GSDMD abolished TMAO-associated cardiac aging. Furthermore, pharmacological inhibition of TMAO production in aged mice attenuated oxidative stress, suppressed NLRP3-mediated pyroptosis activation, and alleviated cardiac aging. SIGNIFICANCE This study revealed that plasma TMAO levels progressively increase with age in mice and TMAO contributed to cardiac aging in a time-dependent manner through NLRP3-mediated pyroptosis driven by oxidative stress. Moreover, the inhibition of TMAO generation might offer a basis for future therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2026) studied Cardiac aging. TMAO and 3,3-dimethyl-1-butanol was evaluated on Cardiac function, senescence markers, oxidative stress, and pyroptosis protein expression. TMAO administration in mice promoted cardiac aging and diastolic dysfunction through NLRP3-mediated pyroptosis, which was attenuated by pharmacological inhibition of TMAO production.
Synapse has enriched 10 related papers. Consider them for comparative context: